EMVision
EMV.AXEMVision Medical Devices Ltd Price (EMV.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
80,437,212
(3.5077)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
EMVision Medical Devices LtdCurrency: AUD
| YEAR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
492,667.00
+0% |
1,414,438.00
+187% |
1,551,477.00
+10% |
1,698,891.00
+10% |
4,360,373.00
+157% |
6,973,161.00
+60% |
11,219,204.00
+61% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 113,959.00 | 243,341.00 | 342,009.00 | 0.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
492,667.00
+0% |
1,414,438.00
+187% |
1,551,477.00
+10% |
1,584,932.00
+2% |
4,117,032.00
+160% |
6,631,152.00
+61% |
11,219,204.00
+69% |
||||||||||||
| Gross Profit Ratio | (1.00%) | (1.00%) | (1.00%) | (0.93%) | (0.94%) | (0.95%) | (1.00%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 955,876.00 | 1,960,457.00 | 2,935,446.00 | 2,707,798.00 | 2,325,364.00 | 2,011,724.00 | 4,697,216.00 | ||||||||||||
| General and Administrative | 198,313.00 | 2,123,696.00 | 727,907.00 | 956,831.00 | 1,287,583.00 | 1,527,287.00 | 1,825,997.00 | ||||||||||||
| Selling, General & Admin... | 381,378.00 | 2,123,696.00 | 2,178,144.00 | 7,362,808.00 | 7,898,467.00 | 8,574,434.00 | 8,136,397.00 | ||||||||||||
| Selling & Marketing Exp... | 183,065.00 | 131,670.00 | 1,450,237.00 | 6,405,977.00 | 6,610,884.00 | 7,047,147.00 | 6,310,400.00 | ||||||||||||
| Depreciation and Amortiz... | 844,587.00 | 2,958,601.00 | 3,562,113.00 | 113,959.00 | 243,341.00 | 342,009.00 | 410,580.00 | ||||||||||||
| Other Expenses | 0.00 | 288,886.00 | 1,601,477.00 | 1,748,891.00 | 4,360,373.00 | 6,973,161.00 | 0.00 | ||||||||||||
| Total Operating Expenses | 1,337,254.00 | 4,373,039.00 | 5,113,590.00 | 10,070,606.00 | 10,223,831.00 | 10,586,158.00 | 12,833,613.00 | ||||||||||||
| Cost and Exponses | 1,337,254.00 | 4,373,039.00 | 5,113,590.00 | 10,184,565.00 | 10,467,172.00 | 10,928,167.00 | 12,833,613.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-1,337,250.00
+0% |
-2,958,601.00
+121% |
-5,113,590.00
+73% |
-10,184,560.00
+99% |
-10,467,170.00
+3% |
-10,928,170.00
+4% |
-1,614,409.00
-85% |
||||||||||||
| Operating Income Ratio | (-2.71%) | (-2.09%) | (-3.30%) | (-5.99%) | (-2.40%) | (-1.57%) | (-0.14%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 452.00 | 761.00 | 36,954.00 | 46,797.00 | 15,640.00 | 119,578.00 | 341,208.00 | ||||||||||||
| Interest Expenses | 467.00 | 761.00 | 597.00 | 9,837.00 | 18,122.00 | 35,277.00 | 115,719.00 | ||||||||||||
| Total Other Income/Exp... | 492,210.00 | -8,078.00 | 980,127.00 | -1,361,318.00 | -2,396,735.00 | 4,556,180.00 | -417,465.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 0.00 | 0.00 | 0.00 | -9,555,549.00 | -7,838,190.00 | -3,493,419.00 | -2,091,208.00 | ||||||||||||
| EBITDA ratio | (-2.71%) | (-2.09%) | (-3.30%) | (-5.93%) | (-2.34%) | (-1.52%) | (-0.19%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -845,040.00 | -2,959,362.00 | -4,133,463.00 | -9,679,345.00 | -8,099,653.00 | -6,371,990.00 | -2,031,874.00 | ||||||||||||
| Income Before Tax Ratio | (-1.72%) | (-2.09%) | (-2.66%) | (-5.70%) | (-1.86%) | (-0.91%) | (-0.18%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -453.00 | -279,135.00 | -657,707.00 | -1,280,631.00 | -1,990,373.00 | -2,501,285.00 | 697,735.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -845,040.00
+0% |
-2,959,362.00
+250% |
-3,475,756.00
+17% |
-8,398,714.00
+142% |
-6,109,280.00
-27% |
-3,870,705.00
-37% |
-2,729,610.00
-29% |
||||||||||||
| Net Income Ratio | (-1.72%) | (-2.09%) | (-2.24%) | (-4.94%) | (-1.40%) | (-0.56%) | (-0.24%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.01 | -0.06 | -0.06 | -0.12 | -0.08 | -0.05 | -0.03 | ||||||||||||
| Diluted EPS | -0.01 | -0.06 | -0.06 | -0.12 | -0.08 | -0.05 | -0.03 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 57,578,750.00 | 46,959,229.00 | 61,404,020.00 | 70,097,275.00 | 75,192,582.00 | 77,711,338.00 | 80,438,792.00 | ||||||||||||
| Diluted Share Outstanding | 57,578,750.00 | 46,959,229.00 | 61,404,020.00 | 70,097,275.00 | 75,192,582.00 | 77,711,338.00 | 80,437,212.00 | ||||||||||||